These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6222065)

  • 41. Comparative susceptibility of anaerobic bacteria to ticarcillin, cefoxitin, metronidazole, and related antimicrobial agents.
    Henderson DK; Chow AW; Guze LB
    Antimicrob Agents Chemother; 1977 Apr; 11(4):679-82. PubMed ID: 856019
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
    Moody JA; Fasching CE; Sinn LM; Gerding DN; Peterson LR
    J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro comparative antimicrobial activity of cefpimizole against clinical isolates from five medical centers.
    Jones RN; Ayers LW; Gavan TL; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1985 Jun; 27(6):982-4. PubMed ID: 4026275
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A study of the in vitro activity of cefoperazone: a comparison with other beta-lactam antibiotics.
    Wise R; Gillett AP; Andrews JM
    Clin Ther; 1980; 3(Spec Issue):149-55. PubMed ID: 6446391
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparative in vitro activity of newer cephalosporins against anaerobic bacteria.
    Chow AW; Bednorz D
    Antimicrob Agents Chemother; 1978 Nov; 14(5):668-71. PubMed ID: 727759
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the activity of cefoperazone, cefuroxime and cefoxitin against Gram-negative bacilli and synergy studies with cefoperazone and ticarcillin.
    Miles HM; Carson M; Pavillard ER
    Drugs; 1981; 22 Suppl 1():15-9. PubMed ID: 6456885
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimicrobial activity and synergism of cefuroxime on anaerobic bacteria.
    Thadepalli H; White DW; Bach VT
    Chemotherapy; 1981; 27(4):252-8. PubMed ID: 7249787
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calibration of the disk diffusion test for trovafloxacin susceptibility testing of four anaerobic species.
    Kronvall G; Holst E
    Clin Microbiol Infect; 2000 Apr; 6(4):195-201. PubMed ID: 11168107
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Susceptibility of anaerobic bacteria to cofoxitin and related compounds.
    Bach VT; Roy I; Thadepalli H
    Antimicrob Agents Chemother; 1977 May; 11(5):912-3. PubMed ID: 879743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cefoperazone: a review of its antimicrobial spectrum, beta-lactamase stability, enzyme inhibition, and other in vitro characteristics.
    Jones RN; Barry AL
    Rev Infect Dis; 1983; 5 Suppl 1():S108-26. PubMed ID: 6221381
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro susceptibility tests with cefoperazone compared with cefotaxime, cefoxitin, cefuroxime, cephaloridine and gentamicin.
    Brenciaglia MI; Cipriani P; Ghezzi MC; Giordano A; Mancini C; Rivanera D; Filadoro F
    Chemioterapia; 1984 Aug; 3(4):246-9. PubMed ID: 6099754
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An update on the in vitro activity of ceftizoxime and other cephalosporin/cephamycin antimicrobial agents against clinically significant anaerobic bacteria.
    Aldridge KE
    Clin Ther; 1990; 12 Suppl C():3-12. PubMed ID: 2202509
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New insights into the activity of third-generation cephalosporins against pneumonia-causing bacteria.
    Jones RN; Erwin ME; Bale M
    Diagn Microbiol Infect Dis; 1992 Jan; 15(1):73-80. PubMed ID: 1580897
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
    Hall WH; Opfer BJ; Gerding DN
    Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits.
    Jones RN; Gavan TL; Barry AL; Thornsberry C; Gibbs DL
    J Clin Microbiol; 1982 May; 15(5):777-86. PubMed ID: 6212596
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative in vitro activities of cefpiramide and apalcillin against anaerobic bacteria.
    Wexler H; Carter WT; Harris B; Finegold SM
    Antimicrob Agents Chemother; 1984 Feb; 25(2):162-4. PubMed ID: 6712200
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro activity of cefoxitin and parenterally administered cephalosporins against anaerobic bacteria.
    Sutter VL; Kirby B; Finegold SM
    Rev Infect Dis; 1979; 1(1):218-23. PubMed ID: 318226
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative antibacterial activity of the new cephalosporin cefcanel against anaerobic bacteria.
    Nord CE; Lindmark A; Persson I
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):550-1. PubMed ID: 2548866
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro activity of moxalactam against anaerobic bacteria.
    Gilchrist MJ; Washington JA
    Rev Infect Dis; 1982; 4 Suppl():S511-5. PubMed ID: 6218560
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dynamics of resistance to cephalosporins.
    Atkinson BA
    Chemioterapia; 1985 Feb; 4(1):19-23. PubMed ID: 3986942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.